Conferences and Meetings on Oncology

Submit a meeting

Select a location:
Argentina (1) - Australia (3) - Austria (1) - Belgium (1) - Croatia (1) - France (1) - Germany (6) - India (2) - Iran (1) - Italy (2) - Japan (2) - Mexico (3) - Netherlands (1) - New Zealand (1) - Poland (1) - Portugal (1) - Singapore (3) - Spain (2) - Switzerland (2) - United Arab Emirates (3) - United Kingdom (11) - United States (19) - Vietnam (1)

ALL COUNTRIES

1
EACR-AACR-SIC 2017 Special Conference
24 Jun 2017 - 27 Jun 2017 • Florence, Italy
Abstract:
Hosted by the European Association for Cancer Research (EACR), the American Association for Cancer Research (AACR) and the Italian Cancer Society (SIC), the EACR-AACR-SIC Special Conference 2017 “The Challenges of Optimising Immuno and Targeted Therapies: From Cancer Biology to the Clinic” will build on the success of the previous conference, which was widely praised for the quality of its programme and inspirational contributions. The conference format is designed to bring together basic, translational and clinical researchers, as well as researchers working on the development of new targeted therapeutics. Leading experts will present the latest achievements of multidisciplinary research dealing with drug action and resistance and highlight challenges that require a concerted multidisciplinary effort.
Contact:
Email: EAS2017@ecco-org.eu
Topics:
Oncology, Immunotherapy, Targeted therapies, Translational research, Clinical researcher, Targeted therapeutics, Drug resistance
Event listing ID:
842316
2
Oncologic Imaging Course 2017
29 Jun 2017 - 01 Jul 2017 • Dubrovnik, Croatia
Event listing ID:
908073
Related subject(s):
Event website:
3
2nd DNA Replication as a Source of DNA Damage Conference
03 Jul 2017 - 06 Jul 2017 • Rome, Italy
Abstract:
The maintenance of genome integrity is critical for the suppression of cancer and premature ageing. Only recently has it become appreciated that DNA replication stress is a crucial driver of genomic instability. The timely progression of replisomes can be disrupted by lesions and secondary structures in the template, by bound proteins and by conflicts with the transcription machinery. A prolonged pause of the replisome then exposes single stranded DNA, which, due to its recombinogenic nature, can lead to genome rearrangements, fragile site expression and cell death. Importantly, some cancers present excessive endogenous levels of replication stress, which can be exploited for their clearance. In this conference, we aim to bring together scientists studying DNA replication and repair, with those interested in how DNA damage can influence cancer and ageing.
Contact:
Laura Trundle;     Email: laura@fusion-conferences.com
Topics:
DNA Replication, DNA Damage, Cancer, Ageing
Event listing ID:
814137
Related subject(s):
4
Best of ASCO 2017
14 Jul 2017 - 16 Jul 2017 • Chandigarh, India
Abstract:
The Best of ASCO® is an annual educational initiative that condenses highlights from ASCO's Annual Meeting every year. The Scientific committee will select specific abstracts for presentation, based on its relevance, impact on day to day practice and the needs of oncology professionals in India.
Contact:
Dr. Gautam Goyal;     Phone: [+91-81958-49111];     Email: goyal_gautam@yahoo.com, bestofascoindia2017@yahoo.com
Topics:
Recent advances in understanding of cancer genetics, diagnosis and cancer therapeutics. All cancers including gastrointestinal, genitourinary, gynaecological, lung, breast, brain cancer will be discusses. Hematological malignancies, pediatric cancers and others will be discussed by the eminent Medical, Radiation and Surgical Oncologists, Immuno-Oncologist, Palliative care specialists and social support providers. This conference will provide us the insight into the recent advances in cancer care.
Event listing ID:
883235
5
FASEB SRC — Hematologic Malignancies
23 Jul 2017 - 28 Jul 2017 • Saxtons River, VT, United States
Abstract:
This SRC focuses on bringing together biochemists, geneticists, molecular biologists and clinicians interested in the pathophysiology of the leukemias and lymphomas, and the development of novel therapies for these diseases. Leukemia and lymphoma has provided a number of key paradigms for molecularly targeted cancer therapy, as illustrated by the remarkable success of all-trans-retinoic acid for the treatment of acute promyelocytic leukemia and tyrosine kinase inhibitor therapy for chronic myelogenous leukemia. New and promising small-molecule compounds and antibodies targeting epigenetic regulators, surface receptors and downstream signaling pathways are currently under development and will be discussed at this meeting. Added to these examples of targeted therapy, immunotherapy, including checkpoint inhibition and modified T cell-based therapies have emerged as important future anti-leukemia/lymphoma treatments.
Contact:
FASEB SRC Staff;     Phone: [3016347010];     Email: src@faseb.org
Topics:
cancer, stem cell, hematology, genetics, molecular biology, lymphoma/leukemia
Event listing ID:
876987
6
Precision Lung Cancer summit
25 Jul 2017 - 26 Jul 2017 • Boston, United States
Abstract:
Neo Synth presents the Annual Precision: Lung Cancer World Summit taking place on July 25-26 2017 in Boston, USA. Over the two days, this exclusive summit will bring together will bring together senior scientists and business leaders from pharma, biotech and academia, using extensive networking sessions to forge meaningful collaborations.
Contact:
Grace Hamilton;     Phone: [6175005172];     Email: grace@neo-synth.com
Topics:
oncology, immunotherapies, lung cancer
Event listing ID:
912740
Related subject(s):
7
Innate Killer Summit
25 Jul 2017 - 27 Jul 2017 • San Diego, United States
Abstract:
The Innate Killer Summit 2017 is dedicated to help you take critical steps to enhance your biological understanding, ensure successful translation and effective clinical development of natural killer, NKT & γδ T cell immunotherapies.
Contact:
Email: info@hansonwade.com
Event listing ID:
908562
Event website:
8
Lancet Summit: COPD and Lung Cancer
28 Jul 2017 - 29 Jul 2017 • Perth, Australia
Contact:
Marie-Claire Morley;     Email: m.morley@elsevier.com
Topics:
This new Summit, organised by The Lancet Respiratory Medicine and The Lancet Oncology, will cover all of the main areas of debate for patients with COPD and lung cancer from prevention, diagnosis, treatment through to palliative care. It will also look at shared lessons from having a better understanding of the development and management of both diseases. Abstracts are invited by April 17, 2017 for presentation as posters to supplement the invited lectures on the following topics:  Prevention of COPD and lung cancer  Screening for COPD and lung cancer  Genetic insights into disease development  Disease management and current interventions  COPD and lung cancer: latest insights into treatment paradigms  Infectious complications in patient management  Latest advances in surgery and radiation  Post treatment and end of life care The conference will be of interest to clinicians, oncologists, researchers, nurses, policy makers, and public and global health advocates working in respiratory diseases and lung cancer.
Event listing ID:
848711
Related subject(s):
9
FASEB SRC — Protein Kinases and Protein Phosphorylation
06 Aug 2017 - 11 Aug 2017 • Cambridge, United Kingdom
Abstract:
This conference focuses on the biology of protein kinases and phosphorylation signaling. Among FASEB’s longest-running SRCs, it brings together a dynamic international community of junior investigators, trainees, and established researchers from a field that is achieving startling new insight and medical breakthroughs. The program will link detailed understanding of protein structure and biochemical mechanism to control of large-scale processes like the cell division cycle, cell morphogenesis, and metabolism. This SRC will explore the field’s latest research, which is revealing surprising mechanisms of regulation, previously unappreciated subcellular organization, logic of pathways that coordinate diverse intracellular systems. Importantly, derangement of kinase signaling underlies disease, including cancer and diabetes. Drugs targeting kinases and phosphorylation have achieved dramatic cures and promise more, and the conference has consistently offered a robust platform for clinically important work.
Contact:
FASEB SRC Staff;     Phone: [3016347010];     Email: src@faseb.org
Topics:
Pharmacology, Signaling, Molecular Biology, Biochem, Cancer
Event listing ID:
877050
Related subject(s):
10
FASEB SRC — Reversible Acetylation on Health and Disease (HDACs)
06 Aug 2017 - 11 Aug 2017 • Big Sky, Montana, United States
Abstract:
Over the past few years, the “epigenetic” regulation of the genome has become increasingly important to understanding both the etiology and fundamental mechanisms of aging and age-related diseases. Key to epigenetic regulation are two classes of lysine-modifying enzymes, the histone deacetylases (sirtuins and HDACs) and the histone acetyltransferases (HATs). Both classes of enzyme are critical for maintaining youthful gene expression patterns, cell cycle progression, DNA repair, stem cells, mitochondria, cell fate, differentiation, cognition, energy utilization, and the pathogenesis of most age-related diseases. Alterations in sirtuin and HDAC function have been linked to neurodegenerative disorders, muscle wasting, cardiac hypertrophy, cancer, HIV infection, and more generally the process of aging. Several HDAC inhibitors have been approved by FDA to treat various cancers. Small molecule modulators of sirtuins are currently in clinical trials for the treatment of cancers, neuromuscular disorders, inflammatory and metabolic disorders. With particular relevance to aging, the sirtuins, a subclass of HDAC, were first identified in yeast genetic studies as regulators of lifespan and the health benefits of dietary restriction. Activation or overexpression of sirtuins have been shown to protect mice and primates from diseases of aging, and extend mean and maximum lifespan of mice. Therefore, a thorough understanding of sirtuins and HDACs is required, not merely for understanding the regulation of chromatin structure, gene regulation and protein function, but also because these enzymes are intimately involved in normal and abnormal cellular processes that greatly impact human health. Although targeting HATs for therapeutic purposes has been relatively slow compared to targeting deacetylases, exciting new progress has also been made in recent years. Importantly, targeting the bromodomains present in many HATs has attracted a lot of attention lately.
Contact:
FASEB SRC Staff;     Phone: [3016347010];     Email: src@faseb.org
Topics:
aging, stem cell, cancer, differentiation, structural biology
Event listing ID:
871116
Related subject(s):
11
ICAHO2017 — International Conference on Advances in Hematology and Oncology
12 Aug 2017 - 13 Aug 2017 • Coeur d'Alene, United States
Abstract:
The goal of 5th International Conference on Advances in Hematology and Oncology (ICAHO 2017) is to improve the care of hematology and oncology patients by updating the hematology and oncology care providers about the new developments in the field. This ICAHO 2017 conference also provides attendees with opportunities to interact and network with top experts in hematology and oncology. We will have educational and scientific sessions.
Contact:
Tara Shah;     Phone: [3605244696];     Email: support@binayfoundation.org
Topics:
Cancer, Blood disease, Cancer research, Hematology, Oncology
Event listing ID:
844225
Related subject(s):
12
IPOS 2017 — 19th World Congress of Psycho-Oncology and Psychosocial Academy
14 Aug 2017 - 18 Aug 2017 • Berlin, Germany
Contact:
Katharina Friedrich;     Phone: [+49 3643 2468-142];     Email: katharina.friedrich@kukm.de
Topics:
Psychoonkologie, international, International Psycho-Oncology Society (IPOS), German Cancer Society (DKG), German Association of Psycho-Social Oncology (dapo), German Society of Medical Psychology (DGMP), German College of Psychosomatic Medicine (DKPM), German Society for Rehabilitation Sciences (DGRW), the German Association for Social Work in Health Care (DVSG) and the Federal Consortium for Psychosocial Counselling of Outpatients with Cancer (BAK).
Event listing ID:
854419
Related subject(s):
Event website:
13
MLCC 2017 — 3rd Multidisciplinary Lung Cancer Conference
19 Aug 2017 - 20 Aug 2017 • Singapore, Singapore
Abstract:
The event will be held on August 19 - 20 at the Grand Copthorne Waterfront Singapore. This year’s theme “Improving patient care through collaboration” aims to highlight how major scientific discoveries and technology developments are rapidly transitioning to the clinic and keep participants informed of the latest updates in the preclinical and clinical aspects of the ever-evolving field. Building on the success of the previous conferences, international and national speakers will gather to discuss the science and advances in the treatment and prevention as well as the multidisciplinary management of lung cancer and thoracic malignancies.
Contact:
Stella Chee;     Phone: [+6763795267];     Email: secretariat@lccs.com.sg
Topics:
Pathogenesis of lung cancer Diagnostic techniques in lung cancer Lung cancer genomics and other high throughput “omics” studies Biomarkers Novel therapeutics and clinical trials Supportive care Cancer prevention Lung cancer screening Health economics Tobacco control In vitro and in vivo models Current Therapeutics Immunotherapy
Event listing ID:
915532
Related subject(s):
Event website:
14
Hematology, Oncology & Blood & Marrow Transplant for NPs & PAs 2017
19 Aug 2017 - 20 Aug 2017 • Rochester, United States
Abstract:
This program provides NPs and PAs with cutting-edge information on caring for patients in Oncology, Hematology, and Blood and Marrow Transplant for the novice and seasoned provider. As a world renowned medical center striving for excellence in patient care, innovation and research, come and learn with your fellow NPs & PAs about the active roles that advanced practice providers are playing in advancing the constantly evolving fields of Hematology, Oncology and Blood and Marrow Transplant. This course is designed for Nurse Practitioners, Physician Assistants, Advance Practice Nurses, Nurses, Allied Health Professionals with and interest in Hematology, Oncology and Blood and Marrow Transplant.
Event listing ID:
909053
Related subject(s):
15
IMX — Immuno-Oncology Summit 2017
28 Aug 2017 - 01 Sep 2017 • Boston, MA, United States
Abstract:
The Immuno-Oncology Summit will return to Boston again this August 28-September 1 with the goal of supporting researchers in developing the next generation of immunotherapies. Immuno-oncology researchers are changing the way we treat cancer by unleashing the immune system and achieving functional cures in some cancers. This year's IO Summit has been designed to give attendees a complete picture of the field and its advances with 12 conference tracks, 1 in-depth training seminar, and 4 instructional short courses. Topics include immunotherapy discovery, development, biomarkers, and translational oncology as well as emerging topic areas such as cancer vaccines, oncolytic viruses, and advances in synthetic biology techniques. Overall, this event provides a focused look at how researchers are applying new science and technology in the development of effective and safe immunotherapies.
Contact:
Phone: [7819725400];     Email: chi@healthtech.com
Topics:
Immunomodulatory Antibodies, Combination Immunotherapy, Techniques in Synthetic Biology, Immunology for Drug Discovery Scientists, Preclinical & Translational IO, Immuno-Oncology Targets, Adoptive T Cell Therapy, Quantitative Immune Profiling, Biomarkers for Immuno-Oncology, Oncolytic Virus Immunotherapy, Advances in Vaccine Technologies, Vaccine Adjuvants, Personalized Cancer Vaccines
Event listing ID:
897956
Related subject(s):
16
Gynecologic Cancers 2017 — 2nd International Congress on Contemporary Issues in Women Cancers and Gynecologic Oncology
29 Aug 2017 - 30 Aug 2017 • London, United Kingdom
Abstract:
Gynecologic cancer is an uncontrolled growth of abnormal cells that originate from the reproductive organs. There are several types of Gynecologic cancer which include cervical, ovarian, uterine/endometrial, Vaginal and vulvar Cancer. 2nd International Congress on Contemporary Issues in Women Cancers and Gynecologic Oncology 2017 welcomes Gynecologists, Oncologists, Pathologists, Radiologists, Scientists, Research Associates, PhD scholars, Doctors, Nurse and Medical Professionals to be a part of the conference during August 29-30, 2017 London, UK
Contact:
christine zoel;     Phone: [7025085200];     Email: zoelchristine@gmail.com
Event listing ID:
883124
Related subject(s):
17
5th SRC — 5th Singapore Rehabilitation Conference
07 Sep 2017 - 08 Sep 2017 • Singapore, Singapore
Abstract:
The Singapore Rehabilitation Conference is the only regular general rehabilitation conference in Singapore and regionally. Topics are relevant across all levels of rehabilitation including Acute Hospitals, Community/Rehabilitation Hospitals and Community Rehabilitation Facilities. Clinicians, scientists, academics and administrators from Healthcare, Universities and the Industry will participate in this comprehensive programme. Programme hihglights include (1) strong contemporary focus on Geriatric & Cancer Rehabilitation relevant in rehab practice today, (2) covers established fields in Stroke, Spinal Cord, Traumatic Brain Injury, Cardiopulmonary & Musculoskeletal Rehabilitation including Hip Fractures, (3)Systems of Care including health services rehabilitation research, tele-rehabilitation and integrated care delivery and (4) Frontiers in Rehabilitation including ICU Rehab, Rehabilitation Technology, Brain Stimulation, Robotics and Virtual Reality.
Contact:
5th SRC Organising Secretariat;     Phone: [+6565767658];     Email: src_secretariat@sgh.com.sg
Topics:
Rehabilitation, Geriatric, Cancer, Stroke, Spinal Cord, Traumatic Brain Injury, Cardiopulmonary & Musculoskeletal Rehabilitation, Systems of Care, health services rehabilitation research, tele-rehabilitation, integrated care delivery, Rehabilitation Technology, Brain Stimulation, Robotics and Virtual Reality
Event listing ID:
903516
18
LBM2017 — London Breast Meeting 2017
07 Sep 2017 - 09 Sep 2017 • London, United Kingdom
Abstract:
The international London Breast Meeting, now in its 4th year, has established itself as an essential meeting in the academic calendar, aiming to deliver an inspiring and thought-provoking programme in oncological, reconstructive and aesthetic breast surgery. This year we will be focusing on the new innovations in the field, including the topics of breast cancer treatment, robotics, implant technology, autologous reconstruction and aesthetic surgery.
Contact:
Lisa Freeman;     Phone: [02075016762];     Email: lisa.freeman@markallengroup.com
Topics:
Surgery, breast surgery, plastic surgery, reconstructive surgery, aesthetic surgery, oncology
Event listing ID:
898916
Related subject(s):
19
I4CM — International Conference of Current Cancer Medicine
07 Sep 2017 - 09 Sep 2017 • Warsaw, Poland
Abstract:
On behalf of APERO International Organization for Practical Education and Research, APCO Intl. LTD and The Scientific committee, we would like to invite you to join us in Warsaw for the I4CM-2017 (International Conference of Current Cancer Medicine). Our aim is to provide expert teaching from the world’s most acclaimed Cancer surgeons and researchers in a friendly environment to share techniques and ideas. On the other hand, we will introduce the most recent research advances in the basic and clinical aspects of cancer medicine.

http://i4cm.net/

Submission by e-mail is not recommended, but in case of difficulty do not hesitate to contact us at apcomed2017@gmail.com.

Contact:
Peyman Zare;     Phone: [+48884842847];     Email: apcomed2017@gmail.com
Topics:
Cancer, Tumor, Oncology, Breast, Medications, Research, Survival, Treatment, Cervical, Chemotherapy Anemia, Colon, Colorectal, Leukemia, Lung, Lymphoma, Melanoma, Ovarian, Prostate, acute, adenocarcinoma, adenomaadrenal, anaplastic, armpit, astrocytoma, atelectasi, atypical, aware, benign, biopsy, bladder, blood, bone, bph, brain, brca, calcify, cancerous, carcinoid, carcinoma, cause, cell, cervical, cervix, chemo, chemotherapy, cll, cml, colon, colonoscopy, colorectal, colposcopy, contraindication, curable, cure, cyst, cytology, dermoid, diagnosis, different, disease, dosage, dose, drug, duct, dysplasia, effects, effusion, emphysema, endocrine, endometrial, enlarge, esophageal, esophagus, expectancy, fibroadenoma, fibrosi, follicular, gland, glioblastoma, glioma, hcl, hemangioma, hematocrit, hemoglobin, histology, Hodgkin, hormone, hpv, hydrochloride, hyperplasia, immune, immunotherapy, indication, infiltrate, infusion, injection, intraepithelial, intravenous, iv, kidney, lesion, leukaemia, leukemia, lidocaine, lipoma, liposarcoma, liver, lobular, lump, lumpectomy, lung, lymph, lymphadenopathy, lymphatic, lymphedema, lymphoblastic, lymphocytic, lymphoid, lymphomamalignancy, malignant, mammogram, marrow, mastectomy, mechanism, mediastinal, melanoma, mesothelioma, metastase, metastasi, metastasize, metastatic, methotrexate, mg, mgu, mole, monoclonal, mucinous, multiple, myeloid, myeloma, neck, neoplasia, neoplasm, neuroblastoma, neuroendocrine, neutropenia, nevu, node, nodular, nodule, oncologist, oral, osteosarcoma, ovarian, ovary, pancreas, pancreatic, pappapillary, papilloma, parathyroid, parotid, pathology, patient, pharmacokinetic, pituitary, pleural, pneumonia, polycythemia, polyp, precancerous, prognosis, prostate, prostatectomy, prostatitis, psa, pulmonary, radiation, radiotherapy, rectal, recurrence, renal, resection, sarcoma, side, sign, smear, smoking, squamous, stage, staging, steroid, subcutaneous, surgery, survival, swollen, symptom, tablet, teratoma, testicular, therapy, thyroid, tissue, transfuse, tumour, type, ultrasound, uterine
Event listing ID:
908946
Related subject(s):
Event website:
20
ESMO 2017 Congress
08 Sep 2017 - 12 Sep 2017 • Madrid, Spain
Abstract:
“Integrating science into oncology for a better patient outcome.” In an era of deep understanding of the molecular biology underlying the development of cancer, it is crucial that researchers and clinicians exchange knowledge. The ESMO 2017 Congress, in partnership with EACR, will bring oncology professionals together to facilitate interaction and bridge knowledge sharing between the laboratory and clinic. The aim of ESMO 2017 is to work together, aligning the objectives of researchers and clinicians, in order to provide more precise direction leading to better treatment options for cancer patients. The ESMO Congress is  the  most influential annual meeting for oncology professionals in Europe. We invite you to save the date.
Event listing ID:
799894
21
Biomarkers USA — 2nd Annual Biomarkers & Precision Medicine USA Congress
09 Sep 2017 - 11 Sep 2017 • San Diego, United States
Abstract:
Over 250 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions. Over 40 presentations, case studies and panel discussions focused on the key issues in biomarker research, companion diagnostics, personalised medicine and clinical biomarkers.
Contact:
Oxford Global Global;     Phone: [1865248455];     Email: a.fernandez@oxfordglobal.co.uk
Topics:
biomarker research companion diagnostics personalised medicine clinical biomarkers
Event listing ID:
914903
22
CRRM — Innovations on Cancer Research and Regenerative Medicine
10 Sep 2017 - 13 Sep 2017 • Ho Chi Minh, Vietnam
Abstract:
The 3rd CRRM, the international conference about Cancer Research and Regenerative Medicine co-organized by University of Science, VNU-HCM, Viet Nam; University of California, Los Angeles (UCLA), US; and MD Anderson Cancer Center, The University of Texas, US will be held at the University of Science, VNU-HCM, Ho Chi Minh on Sept 10-13, 2017. CRRM is an international forum for all scientists, researchers, doctors, students about cancer research and regenerative medicine. The conference consistently draws senior- and junior-level professionals from multiple sectors, providing a valuable combination of experience, enthusiasm, and varied perspectives to the discussions.
Contact:
Phuc Van Pham;     Email: crrmconference@gmail.com
Topics:
Cancer, Stem cell, Tissue engineering, Regenerative medicine, Tumor, Biomedical engineering, Biomedical Science
Event listing ID:
875688
23
International Meeting on Molecular and Cancer Biomarkers — International Meeting on Molecular and Cancer Biomarkers
10 Sep 2017 - 10 Oct 2017 • Dubai, United Arab Emirates
Abstract:
Meeting International welcomes every one of the members over the globe to attend International Meeting on Molecular and Cancer Biomarkers during October 09-10, 2017 in Dubai, UAE which incorporates incite keynote presentations, Oral talks, Poster presentations and Exhibitions.
Contact:
Tiara Cruise;     Phone: [3022316756];     Email: tiaracruise1994@gmail.com
Topics:
Cancer Biomarkers conference, Molecular Biomarkers conference, Cancer conferences
Event listing ID:
909670
Related subject(s):
24
Radiology in paediatric oncology - an update
22 Sep 2017 • London, United Kingdom
Abstract:
This event will provide an update on the current major challenges faced by clinicians dealing with children who present with some of the commoner tumours of childhood, both from an oncology perspective but also from a radiological viewpoint. The speakers comprise some of the leading paediatric oncologists and radiologists from around the UK. The lecture topics include neuroblastoma, Wilms’ tumours, rhabdomyosaroma, osteosarcoma, and lymphomas plus sessions on functional imaging and interventional radiology in pediatric oncology. The day will finish with some interactive case sessions.
Contact:
Malini Banerjee;     Phone: [02036682226];     Email: Malini.Banerjee@bir.org.uk
Topics:
Oncology, paediatric, radiology, neuroblastoma, Wilms' tumours, tumour, rhadomyosaroma, osteosarcoma, lymphoma, leukaemia, interventional, imaging, diffusion weighted imaging.
Event listing ID:
883763
Related subject(s):
25
CANCER VAC — SMi's 6th annual Cancer Vaccines Conference
27 Sep 2017 - 28 Sep 2017 • London, United Kingdom
Abstract:
SMi Group is thrilled to present the 6th annual Cancer Vaccines conference, taking place on 27th & 28th September 2017 in Central London, UK. Overcoming hurdles to cancer immune response: Cell therapies, vaccine development and combination therapies. Aimed at an audience of senior scientists and oncology specialists involved in targeted vaccines and drug research, Cancer Vaccines 2017 will provide a perfect platform to discuss pioneering clinical developments and the next generation of cancer immunotherapy. The 6th annual show will capture expert insight by honing in on new pathways with novel vaccines and immunotherapies, drug formulations, personalised treatment, immune check-point inhibitors, plus more.
Contact:
Kyra Williams;     Phone: [02078276012];     Email: kwilliams@smi-online.co.uk
Topics:
Cancer vaccines; combination cancer immunotherapy; CAR, T-Cell; Dendritic Cells; Epitopes, Cancer, vaccine, combination therapies, adjuvants, chimeric antigen receptors, cells, immunotherapies, tumour, efficacy, delivery, therapeutic vaccines, immune monitoring, PDL-1, CTLA4, monoclonal antibodies, conference, London; tumour, immune, genetic heterogeneity, angiogenic, immune-oncology, oncology, rna, immunogen, immune, personalized therapy, protein, biomarker, disease, novel pathway, molecular, vaccinology, cell-based, liposomes, dna, peptide, vaccine
Event listing ID:
903502
26
EUS ENDO — EUS ENDO International Live Course
28 Sep 2017 - 29 Sep 2017 • Marseille, France
Abstract:
EUS-ENDO will offer one day of live transmission from Paoli-Calmettes Institute to the Villa Méditerranée in the new center of Marseille. We have invited worldwide experts on EUS and Endoscopy, they will give lectures and will demonstrate the last developments of these technologies (ERCP, ESD, Therapeutic EUS, etc….) during the live demonstrations. New scopes will be showed as new accessories. The main goal of this meeting will be to demonstrate the complementarity of EUS and ERCP for bilio-pancreatic diseases, to show also new procedures as radiofrequency ablation of bilio-pancreatic cancers, cholangio-pancreatoscopy, confocal laser endomicrsocopy, etc…

The second day will be dedicated to hands on, 6 stations will be available for ERCP, EUS-FNA, T.EUS, GI bleeding management, EMR &ESD. This second day should be interactive between the participants and the experts, 4 workshops will be organized and also 3 sessions of oral communications in which participants will debate with the experts. Abstracts presented during EUS-ENDO will be published in Endoscopic Ultrasound review.

Contact:
Sylvie Martel;     Phone: [+33 7 79 69 67 68];     Email: sylvie.martel@mcocongres.com
Topics:
endoscopy, bilio-pancreatic diseases, cholangio-pancreatocopy, confocal laser endomicroscopy,
Event listing ID:
850717
Related subject(s):
27
Cancer Conferences, Cancer Meetings, Cancer Symposiums, Cancer Conferences USA — 2nd World Congress on Cancer Research & Therapy
02 Oct 2017 - 04 Oct 2017 • San Diego, United States
Abstract:
On Tremendous success of our Cancer Congress-2016, The 2nd World Congress on Cancer Research & Therapy will take place in the gorgeous city of San Diego, USA in October 02-04, 2017 and the theme of the conference is “Aspiration, inspiration and imagination – Cancer research, Treatment and Care”. Cancer Congress-2017 is designed to be a relaxed and friendly meeting where delegates and invited speakers have a chance to interact on both a scientific and social basis. We encourage the speakers to stay for the duration of the conference to ensure this interaction.
Contact:
Jason Clark;     Phone: [3373223608];     Email: cancer@innovincconferences.com
Topics:
cancer conferences, cancer conferences usa, oncology conferences, cancer meetings, cancer symposiums, cancer nursing meetings, 2nd world congress on cancer, world cancer congress, cancer research conferences, cancer therapy conferences, world cancer research conference
Event listing ID:
869132
Related subject(s):
28
7th InterAmerican Oncology Conference
05 Oct 2017 - 06 Oct 2017 • Buenos Aires, Argentina
Abstract:
The 7th. InterAmerican Oncology Conference "Current Status and Future of Anti-Cancer Targeted Therapies" will be held in Buenos Aires, Argentina in October 5th and 6th, 2017.

An outstanding faculty of speakers from the United States and Europe has committed in this meeting.

The conference agenda will focus on new translational advances in the treatment of cancer as well as provide updates of conventional therapies for a number of the most common tumor types. The meeting objectives are designed to introduce the audience to the latest information on targeted therapies, immunotherapies and emerging treatments in early development.

Contact:
Email: oncology@oncologyconferences.com.ar
Topics:
New Anticancer Therapies, Novel Agents in Early Clinical Trials, Melanoma, Breast Cancer, Immunotherapies, Biomarkers for Checkpoint Inhibitors, Genitourinary Cancer, Prostate cancer, Metastatic Renal Cell Carcinoma, Bladder Cancer, Gastrointestinal Cancer, Gastric Cancer, Colorectal cancer, Lung cancer, Mesothelioma, Hematological Malignancies, Leukemia, Multiple Myeloma, Lymphoma
Event listing ID:
814189
Related subject(s):
29
International Meeting on Molecular and Cancer Biomarkers
09 Oct 2017 - 10 Oct 2017 • Dubai, United Arab Emirates
Abstract:
Meeting International   welcomes every one of the members over the globe to attend International Meeting on  Molecular and Cancer Biomarkers during October 09-10, 2017 in Dubai, UAE which incorporates incite keynote presentations, Oral talks, Poster presentations and Exhibitions. "Join us in Dubai, UAE for the International meeting on Molecular and Cancer Biomarkers, the meeting aims to bring together international & regional faculty experts in cancer biomarkers". Meeting International   welcomes every one of the members over the globe to attend International Meeting on  Molecular and Cancer Biomarkers
Event listing ID:
910485
30
Defence is the Best Attack: Immuno-Oncology Breakthroughs
09 Oct 2017 - 11 Oct 2017 • Barcelona, Spain
Abstract:
This new conference to be held in Barcelona, Spain, features an outstanding, internationally renowned faculty who will discuss their up-to-the-minute findings as well as roadmap the 'where to' in identifying novel targets, progressing our understanding of the mechanisms of action of therapeutic interventions, developing improved biomarkers of response to therapy, and overcoming mechanisms of intrinsic and acquired resistance to immunotherapy. With extensive networking opportunities, this conference will provide an intimate setting for top quality scientific interaction.
Contact:
Laura Strachan;     Email: l.strachan@nottingham.ac.uk
Topics:
immuno-oncology, immunotherapy, therapeutic, biomarkers, response, resistance, basic, translational, cancer, research, tumour, immune, immunoediting, checkpoints, microbioma
Event listing ID:
898716
31
Haematological Malignancies
10 Oct 2017 - 11 Oct 2017 • Kensington, United Kingdom
Abstract:
What is Haematological Malignancies? This is a two-day, rapid and progressive education programme on Haematological Malignancies. Led by specialist physicians face-to-face learning equips delegates with the knowledge required to discuss Haematological Malignancies confidently and credibly. Knowledgeable, expert clinicians review the haematological system and providing an overview of the spectrum of haematological cancers. What does heamatological malignancies training programme include? The pathophysiology of haematological malignancies such as leukaemias, lymphomas and myeloma, Treatment and management, The issues and complications of bone marrow and stem cell transplant, Matters relating to clinical trial issues, Case studies, quizzes and open discussion form an integral part of the programme.
Event listing ID:
911662
Related subject(s):
Event website:
32
Breast Cancer Conference — International Meeting on Women’s Health and Breast Cancer
12 Oct 2017 - 13 Oct 2017 • Osaka, Japan
Abstract:
Meeting International welcomes every one of the members over the globe to attend International Meeting on Women's Health and Breast Cancer during October 12-13, 2017 in Osaka, Japan which incorporates incite keynote presentations, Oral talks, Poster presentations and Exhibitions.
Contact:
Briana Wilson;     Phone: [+1-302-231-6756];     Email: breastcancer@meetingseries.org
Topics:
Women, s Health, Breast Cancer, Cervical Cancer, Ovarian Cancer, Diabetes, Pregnancy, PCOD and Menstruation Irregularities.
Event listing ID:
893984
Related subject(s):
33
MAP : MOLECULAR ANALYSIS FOR PERSONALISED THERAPY
13 Oct 2017 - 14 Oct 2017 • Zurich, Switzerland
Abstract:
A joint initiative of Cancer Research UK, UNICANCER and ESMO, this conference shines a light on the latest medical developments on molecular analysis for personalised therapy.
Contact:
Patrick Wahby;     Email: map@overcome.eu
Topics:
Cancer, cancer research UK, unicancer, esmo, molecular analysis, personalised therapy, genome, oncology, metastatic, clinical oncologists, scientific.
Event listing ID:
841144
Event website:
34
TBCC9 — The International Tehran Breast Cancer Congress
18 Oct 2017 - 20 Oct 2017 • TEHRAN, Iran
Abstract:
The International Tehran Breast Cancer Congress (ITBCC) provides a unique multidisciplinary setting for all professionals with a common interest in breast cancer to navigate, discuss, inform and educate themselves about this evolving disease landscape; to debate and deliberate about new data and developments; and to establish what it means for patient treatment and care.

Leading international and national scientists and physicians will address recent advances in breast cancer research, personalized therapy, and the latest clinical data impacting the treatment of breast cancer. Cutting-edge lectures, panel discussions, and interactive question-and-answer sessions will provide a unique opportunity for participants to engage with pioneers as they share their perspectives and personal experiences on the challenges and ongoing controversies in breast cancer.T

Contact:
Secretariat;     Phone: [+9821-88673129];     Email: CONGRESS@IBCRC.IR
Topics:
New concepts in Breast Cancer ; ( Epidemiology, Oncoplatic surgery & reconstruction, Screening & Prevention, Neoadjuvant & Adjuvant therapy, Radiotherapy, Imaging, Genetics & Heredity, Immunotherapy & Cell Therapy, Pathology, Quality of life, Ethical aspects, Medical informatics, Fertility preservation & Tissue engineering)
Event listing ID:
830791
Related subject(s):
35
Joint meeting of the 9th World Congress of Melanoma and 14th International Congress of the Society for Melanoma Research
18 Oct 2017 - 21 Oct 2017 • Brisbane, Australia
Contact:
Vivien Lietze;     Phone: [+4930204590];     Email: congress@worldmelanoma2017.com
Topics:
Dermatology, Dermato-Oncology, Skin-Cancer, Melanoma
Event listing ID:
764380
Related subject(s):
36
Introduction to Cancer Biology and Personalised Cancer Treatments by Dr Elaine Vickers
19 Oct 2017 - 20 Oct 2017 • Manchester, United Kingdom
Abstract:
During the course, Elaine will explain many of the concepts behind the personalisation of cancer care such as: the range of different mutations in cancer cells, the difference between passenger and driver mutations, the appearance of drug resistance and the potential advantages of immunotherapy for cancers without targetable mutations.
Event listing ID:
911856
Related subject(s):
37
2017 Novel Cancer Therapeutics Summit
19 Oct 2017 - 20 Oct 2017 • San Diego, United States
Abstract:
We invite you to attend the 2017 Novel Cancer Therapeutics Summit, to be held on October 19-20, 2017 in San Diego, CA. This summit includes three parallel conferences focused on both the research, and business perspectives in oncology.
Contact:
Kristen Starkey;     Phone: [6262566405];     Email: infogtcbio@gtcbio.com
Topics:
emerging targets, therapeutic strategies, next generation sequencing in cancer diagnosis, progress in cancer immunotherapy, combination strategies in immuno-oncology, advancements in technology, as well as business development trends, markets, partnership opportunities, and access to capital market.
Event listing ID:
902448
38
29th Annual Fall Foliage Cancer Conference
20 Oct 2017 - 21 Oct 2017 • Asheville, United States
Abstract:
Overall Topics:
Contact:
Community Cancer Education, Inc., 900 Hendersonville Rd, Suite 311;     Phone: [8282779706];     Email: sha@shallc.net
Topics:
oncology, cancer, breast, prostate, urology, gyn oncology, conference, fall, foliage, radiation, medical oncology, surgical oncology
Event listing ID:
909341
Event website:
39
ICOR 2017 — International Conference on Oncology and Radiology
23 Oct 2017 - 25 Oct 2017 • Las Vegas, United States
Abstract:
The (ICOR 2017) Conference on Oncology and Radiology is an International Cancer Conference, a professional association that focuses on research in the field of Oncology. The aim of this association by constitution is to promote research in all fields of Cancer and related sciences, to encourage improvements in methods for the prevention and treatment of Cancer, to improve the health of the public through research, and to facilitate cooperation among investigators and the communication of research findings and their implications throughout the world. Plus, you'll have the opportunity to connect with more than 500 of your peers and celebrate your profession. You'll leave better educated and more invigorated than you thought possible. We wish to see you in Las Vegas, a promising place to discover novel things in the field of science and technology.
Contact:
Michal Albert;     Phone: [+1 (702) 988 2320];     Email: cancer@magnusconferences.com
Topics:
cancer conference, cancer conferences, cancer conferences 2017, oncology conference, oncology conferences, oncology conferences 2017, radiology conferences, global summit on oncology and radiology, oncology and radiology conferences 2017
Event listing ID:
874932
Event website:
40
CoBrCa — 3rd World Congress on Controversies in Breast Cancer (CoBrCa)
26 Oct 2017 - 28 Oct 2017 • Tokyo, Japan
Abstract:
The 3rd CoBrCa Congress will continue the tradition of directly addressing controversial issues in breast cancer faced by clinicians in their daily practice. The 3rd CoBrCa will focus on key issues in medical oncology, surgery, radiation oncology, reconstruction and pathology. The congress will provide a forum to effectively debate these unresolved clinical and therapeutic problems.
Contact:
Secretariat;     Email: cobrca@congressmed.com
Topics:
Breast cancer, oncology, Breast imaging, Breast reconstruction,
Event listing ID:
876550
Related subject(s):
Event website:
41
CRT-2017 — II International conference on CANCER RESEARCH AND TARGETED THERAPY
26 Oct 2017 - 28 Oct 2017 • MIAMI, FLORIDA, United States
Abstract:
United Scientific Group (USG) successfully completed I International Conference on Cancer Research and Targeted Therapy at Baltimore USA on Oct 21-23, 2016. With a great spirit and encouragement USG is proud to announce our II International Conference on Cancer Research and Targeted Therapy on Oct 26-28, 2017 at Miami Beach Resort, Miami, Florida, USA.
Contact:
Kinnera;     Phone: [408-426-4832];     Email: cancer.therapy@uniscigroup.org
Topics:
The Cancer Cell, Cancer Metabolism, Cancer Metastasis, Cancer Stem Cell Biology, Cell Signal Transduction in development and Cancer, Molecular Oncology, Cancer Immunology, Checkpoint Inhibitors in Treating Cancers, Monoclonal Antibodies to Treat Cancer, Cancer Vaccines, Antitumor Immunity, Cancer Microenvironment, Tumor Biomarkers, Tumor Angiogenesis, Tumor Imaging, Cancer Models, Cancer Genomics, Organ Specific Cancer, Gynecological Cancer, Pediatric Cancer, Breast Cancer, Lung Cancer, Gastric Cancer, Oral Cancer
Event listing ID:
908582
Related subject(s):
42
Protecting the Code: Epigenetic Impacts on Genome Stability
29 Oct 2017 - 01 Nov 2017 • Berlin, Germany
Abstract:
The maintenance of genome stability takes place in a chromatin environment, and it is increasingly evident that epigenetic regulation is a key component of genome stability. Notably, epigenetic pathways are frequently perturbed in cancer cells. Understanding the interplay between epigenetic regulation and genome stability at a molecular level is critical to cancer biology and has important translational implications. The programme will address the challenges of understanding this complex field and will emphasise new experimental systems for interrogating these pathways. While the emphasis is on understanding molecular mechanisms of epigenetic impacts on genome stability, we will also consider how recent advances can be exploited in the clinic.
Contact:
Roger Doxat-Pratt;     Email: roger.doxat-pratt@nottingham.ac.uk
Topics:
epigenetics, epigenetic, impacts, genome, genomes, stability, DNA, damage, signalling, chromatin, remodelling, histone, modifications, repair, replication, environment, regulation, non-coding, RNAs, Berlin, Harnack
Event listing ID:
898726
43
The 5th Christie Metastatic Spinal Cord Compression Study Day
01 Nov 2017 • Manchester, United Kingdom
Abstract:
The 5th Christie Metastatic Spinal Cord Compression Study Day is an opportunity for attendees to better understand how to manage patients with suspected or confirmed metastatic spinal cord compression throughout the pathway. The day will share good practice and discuss the development of the Manchester Cancer MSCC Coordinator service .
Event listing ID:
911882
44
ABC4 — Advanced Breast Cancer Fourth ESO-ESMO International Consensus Conference
02 Nov 2017 - 04 Nov 2017 • Lisbon, Portugal
Abstract:
ABC has established itself as a major international breast cancer conference. Its primary aim is the development of international consensus guidelines for the management of advanced breast cancer patients. These treatment guidelines are based on the most up-to-date evidence and can be used and adapted to many different health care settings globally.
Contact:
Gabriele Maggini;     Phone: [+41918200950];     Email: communication@eso.net
Topics:
Breast Cancer, Metastatic breast cancer, Advanced breast cancer, Metronomic chemotherapy
Event listing ID:
893910
45
JADPRO LIVE at APSHO 2017
02 Nov 2017 - 05 Nov 2017 • Houston, United States
Abstract:
The fifth annual JADPRO Live conference will be held in conjunction with the annual meeting of the Advanced Practitioner Society for Hematology and Oncology (APSHO) on November 2-5, 2017, at the Marriott Marquis, Houston, TX. APSHO's mission is to improve the quality of care for patients with cancer by supporting critical issues in educational, clinical, and professional development for advanced practitioners in hematology and oncology. JADPRO LIVE at APSHO provides CE-accredited educational sessions presented throughout the conference which will include didactic, interactive, evidence-based and fair-balanced content targeted to the advanced practitioners (APs) in oncology. The audience for this live conference consists of nurse practitioners, physician assistants, clinical nurse specialists, advanced degree nurses, hematology/oncology nurses, pharmacists, and physicians.
Contact:
Ceil Boyce;     Phone: [609-853-0025];     Email: cboyce@harborsidepress.com
Topics:
Oncology, Hematology, nurse practitioners, physician assistants, clinical nurse specialists, advanced degree nurses, hematology/oncology nurses, pharmacists, physicians.
Event listing ID:
910385
46
ESGO 2017 Congress in Vienna — 20th Biennial International Meeting of the European Society of Gynaecological Oncology
04 Nov 2017 - 07 Nov 2017 • Vienna, Austria
Abstract:
Held biennially, ESGO congress offers professionals in Gynaecological Oncology - including clinicians, researchers, residents and students a unique opportunity to learn and discuss the latest medical and scientific developments in gynaecological cancers research, treatment and care, as well as to network with key opinion leaders and peers from around the world.
Contact:
Lucie Lamlova;     Email: lucie.lamlova@esgomail.org
Topics:
the latest medical and scientific development, gynaecological cancers research, treatment and care
Event listing ID:
825944
Related subject(s):
47
EMBL Conference: Cancer Genomics
05 Nov 2017 - 08 Nov 2017 • Heidelberg, Germany
Abstract:
This conference will provide an opportunity to learn about and keep up to date with the rapidly progressing area of cancer genomics. It will cover presentations from cancer genome projects, the areas of cancer functional genomics, systems biology, cancer mouse models and the translation and clinical impact of scientific results obtained. The meeting will bring together leading scientists from across these areas for a unique opportunity to interact and stimulate further integration of these efforts.

European Cancer Genomics research is particularly strong in the Heidelberg area, with three International Cancer Genome Consortium (www.icgc.org) projects being currently pursued with significant participation from Heidelberg institutions, including EMBL. As in our 2015 meeting, a large number of renowned speakers will be invited, with a strong representation of overseas speakers. The atmosphere at the conference will make this an exceptional event with cutting edge science, extensive scientific discussions and ample possibilities for meetings between and after sessions to facilitate in-depth discussions and new collaborations.

Contact:
Phone: [4962213878797];     Email: marketing@embl.de
Event listing ID:
834567
Related subject(s):
48
NCRI — 2017 NCRI Cancer Conference
05 Nov 2017 - 08 Nov 2017 • Liverpool, United Kingdom
Abstract:
The NCRI Cancer Conference is the largest annual cancer research meeting in the UK, attracting over 1,500 participants from across the spectrum of basic, translational and clinical research. We are committed to share and make available to all attendees the best cancer research from all over the world and encourage cross-pollination. The Conference provides a high profile platform where key stakeholders of cancer research come together to discuss, present and showcase high-quality research. The programme covers six main themes - Diagnosis and therapy, Epidemiology and prevention, Health services research, Information, patients and the public, Survivorship and end of life care and the cancer cell and model systems – which are organised in sessions across 4 days. The Conference programme includes plenty of networking opportunities, allowing participants to make the most of their time in Liverpool.
Contact:
NCRI Conference and Events Team;     Phone: [+44 (0)20 3469 5453];     Email: ncriconference@ncri.org.uk
Topics:
Cancer, basic science, translational research, clinical trials, clinical research, collaboration, share, knowledge, latest advances in cancer research, cancer research, diagnosis, therapy, epidemiology, prevention, health, health services, patients, consumers, patient experts, survivorship, end of life care, palliative care, living with and beyond cancer, cancer cell, cancer model systems, networking, abstract submission
Event listing ID:
882454
49
ICC2017 — 2nd Indian Cancer Congress
08 Nov 2017 - 12 Nov 2017 • BANGALORE, India
Abstract:
The Indian Cancer congress is an amalgamation of the four major national oncology associations ( The Association of Radiation Oncologists of India, Indian Association of Surgical Oncology, the Indian Society of Medical & Pediatric Oncologists and the Indian Society of Oncology) . This conference is a planned quadrennial event of these four associations and all other sub specialty associations to improve the quality of cancer care through multidisciplinary interactionand will be held in various parts of the Indian subcontinent once every four years. The ICC2017 conference is scheduled to be held from 9th to 12th November 2017 (with pre-conference workshop held on 8th Nov 2017) in Bengaluru, India.The theme for the conference is “INSIGHT, INNOVATION, INTEGRATION” The field of oncology is rapidly evolving and is in constant flux. What is thought to be true today may very soon be turned on its head by new insights and new innovations. It is therefore prudent and necessary that we the oncology community – periodically stop in our fast tracks and take stock of some important insights and innovations and debate how best we can integrate these innovations into our practice. The congress hopes to attract each and everyone involved in the care of the cancer patient including physicians, basic scientists, patients, survivors , care givers, researchers, investors etc and to provide a platform from which meaningful value addition can emerge.
Contact:
Nalini Rao;     Phone: [9845517681];     Email: nkrao@hotmail.com
Event listing ID:
833884
50
NZBCS-2017 — The New Zealand Breast Cancer Symposium - United for a Cure Through Research
12 Nov 2017 - 14 Nov 2017 • Auckland, New Zealand
Abstract:
We are so pleased that Professor Sir David Lane, Professor Geoffrey Lindeman, Professor Peter Lobie, and Assistant Professor Andrew Green are going to deliver keynote speeches during the conference. In addition, many other clinicians and research scientists have already confirmed their attendance (see the website: www.nzbcs.org.nz). We expect there will be around 250 local and 500 international guests will attend the meeting. The oral presentations and posters will cover all aspects of clinical, translational, and basic research on breast cancer. The meeting will provide a unique and ideal forum for a broad spectrum of researchers, clinicians, health professionals and those with a special interest in breast cancer to discuss research and share ideas for finding a cure for breast cancer.
Contact:
A/Prof Dong-Xu Liu;     Phone: [+64 9 921 9999];     Email: nzbcs@aut.ac.nz
Topics:
Breast Cancer, New Zealand, NZBCS, Auckland, Symposium, Biomarker, Targeted Therapy, Immunotherapy
Event listing ID:
908976
Event website:
51
GMB17 — Genomic Medicine 2017 Benelux Conference
15 Nov 2017 - 16 Nov 2017 • Brussels, Belgium
Abstract:
Genomic Medicine 2017 Benelux is the second annual genomics event and the conference will look at the latest developments in the use of Genomics tools & technologies focusing on Next Generation Sequencing (NGS) to understand human disease. It will take place on 15th & 16th November at the Musée de la Médecine (Museum of Medicine), Campus Erasme, Brussels.
Contact:
Elisabetta Fineschi;     Email: genmedbenelux@biotexcel.com
Topics:
Genomics, Genetics, NGS, Next Generation Sequencing, Bioinformatics, Clinical Genetics, Oncology, Cancer, Clinical Genomics, Molecular Biology, Data Analysis, Human Genetics, Biomarkers, Data Storage, Rare Disease, Micro RNA, Circulating Tumour DNA, Cfdna, Mirna, Epigenetics, Transcriptomics, Oncogenomics, Microbiome, Metagenomics, NGS Data Analysis, Personalized Medicine, Diagnostics, Infectious And Inherited Diseases, Molecular Diagnostics
Event listing ID:
914893
Related subject(s):
52
Cancer Meeting 2017 — World Cancer Meeting
16 Nov 2017 - 17 Nov 2017 • Singapore, Singapore
Abstract:
Meet Global oncologists and Cancer specialists from USA, Europe, Middle East and Asia-Pacific to “World Cancer Meeting” held at Singapore during November 16-17, 2017. The meeting aims to bring together international & regional faculty experts in Cancer.
Contact:
Rachel Geller;     Phone: [800-101-2526];     Email: cancer@oncologymeeting.org
Topics:
• Cancer • Cancer Biology • Cancer Genetics • Precision Medicine and Cancer Therapy • Cancer Diagnosis and Cancer Diagnostics • Stem Cell Therapy • Cancer Case Reports • Novel Approaches to Cancer Therapeutics • Cancer Screening • Resistance and Tumor Evolution • Oncogenomics • Oncology and Hematology • Cancer Epidemiology • Obesity and Cancer • Cancer Management and Prevention
Event listing ID:
910999
53
14. AIO-Herbstkongress
16 Nov 2017 - 18 Nov 2017 • Berlin, Germany
Abstract:
Vom 16. bis 18. November 2017 findet der 14. AIO-Herbstkongress „Update Medical Oncology“ im Hotel Pullman Berlin Schweizerhof statt. Wie schon in den vergangenen Jahren steht der Kongress ganz im Zeichen der klinischen Forschungsarbeit des Themenbereiches der soliden Tumoren und der Translationalen Forschung. Der AIO-Herbstkongress wird inhaltlich von den Arbeits- und Studiengruppen der AIO gestaltet und befasst sich schwerpunktmäßig mit dem wissenschaftlichen Update dieser Studienaktivitäten. Das Format des AIO-Herbstkongresses mit seinen Plenar- und Gruppensitzungen, Symposien und Diskussionsrunden hat sich bewährt, was nicht zuletzt an den steigenden Teilnehmerzahlen und einer umfangreichen begleitenden Industrieausstellung ersichtlich ist.
Contact:
Andreas Kandler;     Phone: [+49 (0)89 549096-77];     Email: aio-herbstkongress@mci-group.com
Topics:
Mammakarzinom und Gynäkologische Tumoren, Ösophagus-/Magenkarzinom, Kolon-/Rektum-/Dünndarmtumoren, Weichteilsarkome/Knochentumoren, Thorakale Onkologie, Urogenitaltumoren
Event listing ID:
873043
54
Oncology Clinical Experience
21 Nov 2017 - 23 Nov 2017 • Leeds, United Kingdom
Abstract:
What is Oncology Clinical Experience? Oncology Clinical Experience is a hospital based oncology training course and combines theoretical teaching with practical example. Physician taught lectures are combined with visits to clinics and delegates have the opportunity to interact with patients in small group sessions. Oncology Clinical Experience offers rapid and progressive face-to-face training taught by clinician experts and the care team.  This course thoroughly equips attendees with theoretical and practical knowledge to discuss Oncology and its treatment confidently and credibly. Participants are provided with an overview of the spectrum of malignant disease and there is unique opportunity for delegates to experience – first hand – the assessment and treatment options utilised within the overall management of patients with malignant disease. Open discussions and case presentations form a key part of the programme. What does this oncology training include? Review of the manifestation, presentation, investigation and management of a range of common solid tumour types – breast, lung, colorectal, gastrointestinal, melanoma, renal, Explanation of imaging techniques and radiotherapy treatment with visits to these departments, Examination of patient management by specialist clinicians working in these tumour areas, The context of cancer care including the epidemiology of cancer and factors affecting treatment choices and prescribers’ decision-making. Topics included in this oncology course: Introduction to oncology and the epidemiology of cancer, Overview of available therapies, current chemotherapy, immunotherapy and radiotherapy practice, Common solid tumour types breast, lung, colorectal, gastrointestinal, melanoma, renal, New therapeutic options in oncology including immunotherapies, Department visits: radiotherapy and chemotherapy suites, outpatient clinics and radiology department. Chairman Professor Chris Twelves, St James’s University Hospital, Leeds, UK Is this hospital based oncology course for me ? This Oncology hospital based programme is designed to meet the broad information and education requirements of a range of pharmaceutical and biotech personnel from R&D, medical affairs, regulatory, strategic marketing and many others from both science and business functions. Accommodation for Oncology Clinical Experience. Details of the venue will be supplied on registration. Accommodation costs are not included in the course fee. However, Healthcare has organised a special bed and breakfast rate at our preferred hotel for delegates who require overnight accommodation – details of how to book will be provided with the joining instructions for the course. We do encourage delegates to book at this hotel, as daily transport from here to the venue will be provided.
Event listing ID:
912096
55
Innovate Cancer 2017 — Cancer Research
27 Nov 2017 - 28 Nov 2017 • Brisbane, Australia
Abstract:
The 2017 Innovate Cancer Research Conferences are a hub that covers the core aspects of Pathophysiology including “Oncology and Cancer Therapy, Blood Cancer, Prostate Cancer, Thyroid Cancer, Breast Cancer, Cervical Cancer, Pancreatic Cancer, Oral Cancer, Gynecologic Oncology, Brain Cancer, Organ specific cancers
Contact:
Phone: [61-1-800-025-686];     Email:  Cancer@innovatecolloquiums.com
Event listing ID:
875595
56
Biomarkers Congress 2017 — Annual World Congress on Biomarkers & Clinical Research
27 Nov 2017 - 28 Nov 2017 • Atlanta, United States
Abstract:
PULSUS brings in a new spin on conferences by presenting the latest scientific improvements in Biomarkers and its clinical researches. Listen to motivating keynotes from thought leaders, pioneers across the globe. Atlanta is all set for an amazing event as PULSUS proudly presents the “Annual World Congress on Biomarkers & Clinical Research” on November 27-28, 2017. PULSUS cordially welcome researchers, academicians, students and business professionals in the field of BIOMARKERS from around the world to participate in the upcoming BIOMARKERS CONGRESS 2017. The meeting for this year will revolve around the theme “Explore the latest Biomarkers development in health and clinical research” thus relaying the most cutting edge findings in the field of Biomarkers Research.
Contact:
Safina Robinson;     Phone: [+1-800-982-0387];     Email: biomarkers@cmesocietyconferences.org
Topics:
Biomarker Conference, Biomarkers Conference 2017, Biomarkers Conferences, Biomarkers Congress, Biomarker Conferences USA, Biomarker Conferences, Biomarkers Congress 2017, Biomarker Conferences 2017, Biomarkers Society Conferences, Biomarkers cme conference
Event listing ID:
884457
Related subject(s):
57
Oncology Summit 2017 — International Oncology Summit
27 Nov 2017 - 28 Nov 2017 • Atlanta, United States
Abstract:
Allied Academies invites all the participants from all over the world to attend 'International Oncology Summit’ during November 27-28, 2017 in Atlanta, Georgia, USA which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. This Summit has the platform to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need. International Oncology Summit will have an anticipated participation of 120+ delegates across the world to discuss the conference goal
Contact:
Rayan Wayne;     Phone: [8008582189];     Email: oncologyevents@alliedconferences.org
Topics:
Cancer Conferences USA, Cancer Meetings 2017, Oncology Conferences USA, Oncology Symposiums 2017, Oncology Conferences Atlanta.
Event listing ID:
902411
Related subject(s):
58
1st joint EACR-MRS Conference on Seed and Soil: In Vivo Models of Metastasis
27 Nov 2017 - 29 Nov 2017 • Berlin, Germany
Abstract:
We are pleased to invite you to join us at the 1st joint EACR-MRS Conference on Seed and Soil: In Vivo Models of Metastasis. Metastasis is responsible for over 90% of cancer patient deaths, largely due to the fact that therapies are generally ineffective against detectable metastatic tumours. This conference aims to address the crucial need to better understand the metastatic process in order to identify effective therapeutic strategies.
Contact:
Laura Strachan;     Email: l.strachan@nottingham.ac.uk
Topics:
metastasis, in-vivo, models, imaging, transgenic, modelling, MRS, therapeutic, strategies, tools, world-leading, latest, cancer, research
Event listing ID:
898703
59
Oncology Trials: Focus on Phase III
29 Nov 2017 - 30 Nov 2017 • London, United Kingdom
Abstract:
What is Oncology: Phase III Trials? Oncology: Phase III Trials is a two-day, rapid and progressive training programme.  Led by specialist physicians face-to-face learning equips delegates with the knowledge required to discuss Oncology Trials confidently and credibly. Oncology: Phase III Trials is a high calibre, two-day training programme presented in London, UK. This interactive and informative course provides a comprehensive overview of the planning and implementation of oncology clinical trials, focusing on Phase III. The course will demonstrate how oncology trials differ in design and conduct from those in other therapy areas. Delegates learn to design trials to minimise the deficiencies that lead to inappropriate interpretation whilst maximising the competitive advantage. Delegates will hear the perspective of currently practicing oncologists with extensive experience of industry clinical trials as well as professionals who will discuss oncology clinical trial statistics and oncology product market entry. What will I learn about oncology clinical trials? You have the opportunity to learn from experts: How oncology trials differ in design and conduct from those in other therapy areas, How to design trials to minimise the deficiencies that lead to inappropriate interpretation whilst maximising the competitive advantage, Practicing oncologists with extensive experience of industry clinical trials & professionals discuss oncology clinical trial statistics and oncology product market entry. Topics include: Introduction to oncology clinical trial design and planning, Informed consent/patient information, The impact of trials on clinical practice, Statistical analysis and reporting, Health economics assessment, Quality of life assessment. Faculty includes: Professor Allan Hackshaw, Deputy Director, Cancer Research UK & UCL Cancer Trials Centre, Cancer Institute, University College London, London, UK Mr Jim Furniss, SVP, Global Market Access, GfK Market Access, UK Professor Chris Twelves, Professor of Clinical Pharmacology and Oncology, St James’s Institute of Oncology, UK Is this oncology clinical trials course for me? Oncology: Phase III Trials is ideal for pharmaceutical, medical technology and biotechnology industry personnel working in the area of oncology. It is appropriate for those involved in clinical research, medical affairs and regulatory functions, as well as individuals in strategic marketing and business functions.
Event listing ID:
912110
Related subject(s):
60
WCC-2017 — World Cancer Conference
29 Nov 2017 - 30 Nov 2017 • Florida, United States
Contact:
Carol Smith;     Phone: [8005204889];     Email: carolsmith.oap@gmail.com
Topics:
Breast Cancer  Colorectal Cancer Lymphoma  Lung Cancer  Blood Cancer Gynecologic cancer  Cancer Treatment and Prevention Herbal Treatments for Cancer Stem Cell Transplants Cancer Diagnosis Cancer Biomarkers Metastatic Cancer  Cancer Genomics Skin cancer
Event listing ID:
898616
61
Global Cancer Meet and Expo
04 Dec 2017 - 06 Dec 2017 • Dubai, United Arab Emirates
Abstract:
Linkin Science, welcomes you all to the Global Cancer Meet and Expo, with the theme “Advanced insights in Cancer Therapeutics” which will be hosted in Dubai during December 04th - 06th, 2017.
Contact:
Daniel Becker;     Phone: [+1 (415) 463-8448 ];     Email: cancermeet@linkinscience.com
Topics:
Cancer therapeutics, Cancer Diagnostics, Cancer Immunology, Clinical Research in Cancer, Metastatic carcinoma, OncoGenomics, Cell Biology and Cancer, Cancer stem cells and drug resistance, Breast cancer, Prostate Cancer, Lung Cancer, Other major cancer types, Cancer Prognosis, Cancer prevention and Management
Event listing ID:
901009
62
PRIMO — Practical Recommendations in Immuno and Molecular Oncology (PRIMO) Meeting
31 Jan 2018 - 03 Feb 2018 • Maui, United States
Abstract:
The PRIMO Meeting is an annual 3-day single-track conference focusing on the practical applications of emerging immuno and molecular oncology. Each day’s agenda is dedicated to specific tumor types, with the top experts sharing the latest data and applying them to real world cases.
Contact:
Jennifer Mahon;     Phone: [1-855-6-PRIMO-8 (1-855-677-4668)];     Email: support@primomeeting.org
Topics:
oncology, immunology, continuing medical education
Event listing ID:
907331
63
Focal 2017 — 10th International Symposium on Focal Therapy and Imaging in Prostate and Kidney Cancer
11 Feb 2018 - 13 Feb 2018 • Noordwijk, Netherlands
Abstract:
The “10th International Symposium on Focal Therapy and Imaging in Prostate & Kidney Cancer” will be he held in Noordwijk - Amsterdam, The Netherlands, on February 11th -13th, 2018. The Symposium was initiated in 2008 and ever since it has been rotating between the USA and Amsterdam. This year’s Symposium is organized by Prof. Jean De la Rosette and his team at the AMC University Hospital in Amsterdam in collaboration with the Department of Urology of Duke University in Durham, NC and the USC Institute of Urology in Los Angeles, CA in the USA.
Contact:
Email: focal@focaltherapy.org
Event listing ID:
873688
Related subject(s):
64
DDRC — 3rd DNA Replication/Repair Structures and Cancer - Fusion Conferences
11 Feb 2018 - 15 Feb 2018 • Cancun, Mexico
Abstract:
Join scientific chairs Prof. Tom Blundell (University of Cambridge) and Prof. John Tainer (LBL & MD Anderson Cancer Center) in Cancun for the third conference in this series, described by Prof. Ben Van Houten from University of Pittsburgh: ‘I can honestly say your meeting, by combining hard core structure-function studies with beautiful biology, hits an important area that many meetings miss; being part of that science is just terrific.’
Contact:
Laura Trundle;     Phone: [01638 724137];     Email: laura@fusion-conferences.com
Topics:
DNA replication, DNA repair, DNA damage, cancer, replication complexes, mutational signatures, kataegis, synthetic lethality, chromatin, chromosome instability, epigenetics, PARP, PARG, metabolic signaling, mitochondrial replication, mitochondrial repair, RNA damage responses, apoptosis
Event listing ID:
884663
Related subject(s):
65
3rd DNA Replication/Repair Structures and Cancer - Fusion Conferences
11 Feb 2018 - 15 Feb 2018 • Cancun, Mexico
Abstract:
The remarkable stability of the human genome is lost in cancer cells due to the failure of efficient and accurate repair in the context of oncogene-induced replication stress and elevated transcription. DNA replication is furthermore emerging as a surprisingly fragile and complex process requiring fork protection and restart, template-switching, R-loop resolution, gap-filling, and repair. Unresolved replication and repair intermediates signal apoptosis. The synthetic lethality and essentiality resulting from replication-repair stresses thus suggest repair inhibitors as tools to control pathway selection and damage outcomes and to design advanced therapeutics. The 3rd DNA Replication/Repair Structures & Cancer conference in February 2018 will focus on structural and mechanistic insights into dynamic protein, chromatin, DNA and RNA complexes acting in DNA replication and repair events relevant to cancer. Conference talks and discussions will center on developing an actionable mechanistic knowledge of DNA replication and repair stress responses suitable to guide advanced intervention strategies for cancer. The conference will emphasize an environment suitable for initiating productive collaborations. It will include vibrant informal and formal discussions together with informative talks and poster sessions. To include late-breaking advances and innovating new investigators, one or more talks for every session will be selected from submitted abstracts. Meeting attendance is limited.
Event listing ID:
912305
Related subject(s):
66
Fusion Conferences — Nuclear Receptors (New Roles for Nuclear Receptors in Development, Health and Disease) - Fusion conference
27 Feb 2018 - 02 Mar 2018 • Cancun, Mexico
Abstract:
Join scientific chairs Charlotte Bevan (Professor of Cancer Biology, Imperial College London), Karen Knudsen (Sidney Kimmel Cancer Center, TJU, Thomas Jefferson University) and Simak Ali (Principal Investigator, Imperial College London) at the Nuclear Receptors (New Roles for Nuclear Receptors in Development, Health and Disease) Fusion conference in Mexico.
Contact:
Sarah Trundle;     Phone: [01638 724137];     Email: sarah@fusion-conferences.com
Topics:
nuclear receptors, physiologically, pharmacologically, ageing, aging, DNA damage repair pathways, therapeutic target, steroid signalling, estrogen receptor, antiestrogens, androgen, aromatase inhibitors, transcriptional processes, drug development, health, disease, cancer, glucocorticoid receptor, nuclear receptor, crosstalk, epigenetic control, epigenetic regulation, circadian rhythms, cellular pathways, breast cancer, NR-targeting, prostate cancer, small molecules, non coding RNA, DNA damage, cell cycle, metabolism, metabolic disease, CNS, Endocrinology, Oncology, Paediatrics, Urology, Gynaecology, Obstetric Medicine, Neuroscience, Cardiology.
Event listing ID:
897919
Related subject(s):
67
48. Kongress der Deutschen Gesellschaft für Endoskopie und Bildgebende Verfahren e.V.
15 Mar 2018 - 18 Mar 2018 • Munich, Germany
Contact:
Martina Wiederkrantz;     Phone: [089 8906770];     Email: martina.wiederkrantz@cocs.de
Event listing ID:
903304
Related subject(s):
Event website:
68
Cancer Imaging and Therapy
02 Apr 2018 - 06 Apr 2018 • Hollywood, United States
Abstract:
The Cancer Imaging and Therapy conference will focus on optical methods in cancer, centered on imaging and treatment of cancer. The conference will accept submissions on topics on the molecular and cellular level, such as reporters and theranostics; on the tissue and pre-clinical (animal) level, such as pathology methods and advances in imaging of tumor models; and on human tissue and living human subjects, when specifically dealing with cancer. More generic biomedical optics and biophotonics research involving human tissues or living human subjects should be submitted to the Clinical and Translational Biophotonics conference at this congress.
Event listing ID:
836362
69
EMBO Workshop — Perspectives on skin cancer prevention
08 Apr 2018 - 11 Apr 2018 • Les Diablerets, Switzerland
Topics:
Molecular Medicine | Cell & Tissue Architecture
Event listing ID:
916393
Related subject(s):


Conference-Service.com offers, as part of its business activities, a directory of upcoming scientific and technical meetings. The calendar is published for the convenience of conference participants and we strive to support conference organisers who need to publish their upcoming events. Although great care is being taken to ensure the correctness of all entries, we cannot accept any liability that may arise from the presence, absence or incorrectness of any particular information on this website. Always check with the meeting organiser before making arrangements to participate in an event!